Atlas Trials

Efficacy, Safety, and Tolerability of SPD489 in Adults With Schizophrenia and Predominant Negative Symptoms

Clinical trial NCT00922272 · COMPLETED

Trial details

NCT number
NCT00922272
Sponsor
Shire
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Schizophrenia and Predominant Negative Symptoms
Start date
2009-09-14
Primary completion
2011-01-20
Enrollment
92

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.